- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
CME Group Maintains 'Market Perform' Rating from Keefe, Bruyette & Woods
Analysts see potential downside for the financial services provider's stock price
Apr. 8, 2026 at 12:37pm
Got story updates? Submit your updates here. ›
Research analysts at Keefe, Bruyette & Woods have reaffirmed a 'market perform' rating on shares of CME Group (NASDAQ:CME), setting a price target of $305.00 which suggests a potential downside of 1.80% from the company's current trading price. Several other analysts have also weighed in on CME Group, with some upgrading the stock while others maintain a neutral stance.
Why it matters
CME Group operates some of the world's largest and most liquid derivatives exchanges, making it a key player in the global financial markets. Analyst ratings and price targets can influence investor sentiment and trading activity around the stock, which in turn impacts the company's valuation and performance.
The details
Keefe, Bruyette & Woods reiterated its 'market perform' rating and $305.00 price target on CME Group in a research note published on Wednesday. The analysts cited the financial services provider's current stock price and market position as factors in their assessment. Other recent analyst actions on CME Group include Weiss Ratings upgrading the stock to a 'buy (a-)' rating, while Royal Bank of Canada increased its price target to $302.00 and maintained a 'sector perform' rating.
- On Wednesday, Keefe, Bruyette & Woods issued its latest research note on CME Group.
- In early March, Weiss Ratings upgraded CME Group's rating.
- In early February, Royal Bank of Canada raised its price target on CME Group.
The players
Keefe, Bruyette & Woods
A financial services firm that provides investment banking, asset management, and research services.
CME Group
A global markets company that operates major derivatives exchanges, including the Chicago Mercantile Exchange, Chicago Board of Trade, and New York Mercantile Exchange.
Weiss Ratings
An independent rating agency that provides research and analysis on financial institutions and investments.
Royal Bank of Canada
A multinational financial services company and one of the largest banks in Canada.
The takeaway
The mixed analyst views on CME Group highlight the ongoing debate around the company's valuation and growth prospects within the evolving financial markets landscape. Investors will likely continue to closely monitor the stock's performance and any further updates from research analysts.





